SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062027
Filing Date
2023-11-09
Accepted
2023-11-09 16:08:11
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20231109.htm   iXBRL 8-K 48692
2 EX-99.1 bolt-ex99_1.htm EX-99.1 357277
3 GRAPHIC img192637872_0.jpg GRAPHIC 3892
  Complete submission text file 0000950170-23-062027.txt   550330

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20231109_lab.xml EX-101.LAB 14018
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20231109.xsd EX-101.SCH 2454
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20231109_pre.xml EX-101.PRE 10277
8 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20231109_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 231392402
SIC: 2834 Pharmaceutical Preparations